Observational study links semaglutide dose and weight loss to lower liver disease risk.
Study links semaglutide use to lower risk of several liver conditions in patients with liver disease
This observational study from a real-world federated EHR network analyzed 6,734 patients with liver disease. It found associations between h…
Higher semaglutide doses and greater weight loss were linked to lower risks of steatohepatitis, alcoholic liver disease, and death in patien…
Continuous terlipressin infusion reduces treatment failure and rebleeding in acute variceal bleeding
Could a different way of giving a bleeding drug save more lives?
A meta-analysis of 6 RCTs (n=494) in cirrhosis patients found continuous terlipressin infusion reduced treatment failure (RR 0.32) and reble…
A slow drip of the bleeding drug terlipressin works better than a quick shot, causing fewer side effects and less rebleeding for patients wi…
Case report: Liver transplant recipient on dialysis for over 10 months recovered kidney function
Can a transplanted liver help a failing kidney recover after months on dialysis?
A case report describes a single liver transplant recipient with pre-transplantation acute kidney injury attributed to hepatorenal syndrome …
A patient on dialysis for over 10 months recovered kidney function after a liver transplant, challenging the belief that long-term dialysis …